99 related articles for article (PubMed ID: 6262091)
1. Antimacrophage agents decrease the antitumor effect of a water-soluble carboxymethylated (1 leads to 3)-beta-D-glucan.
Sasaki T; Tanaka M
Eur J Cancer (1965); 1980 Sep; 16(9):1271-3. PubMed ID: 6262091
[No Abstract] [Full Text] [Related]
2. Promotion of incidence of adenovirus type 12 transplantable tumors by carrageenan, a specific antimacrophage agent.
Lotzová E; Richie ER
J Natl Cancer Inst; 1977 Apr; 58(4):1171-2. PubMed ID: 191626
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
Keller R
J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
[TBL] [Abstract][Full Text] [Related]
4. Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica.
Lotzova E; Gallagher MT; Trentin JJ
Biomedicine; 1975 Sep; 22(5):387-92. PubMed ID: 177111
[TBL] [Abstract][Full Text] [Related]
5. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
Kataoka T; Oh-hashi F; Sakurai Y; Gomi K
Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
[TBL] [Abstract][Full Text] [Related]
6. Promotion of tumor growth in vivo by antimacrophage agents.
Keller R
J Natl Cancer Inst; 1976 Dec; 57(6):1355-61. PubMed ID: 187804
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan.
Cudkowicz G; Yung YP
J Immunol; 1977 Aug; 119(2):483-7. PubMed ID: 196023
[No Abstract] [Full Text] [Related]
8. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
Ohno N; Kurachi K; Yadomae T
J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
[TBL] [Abstract][Full Text] [Related]
10. Macrophage involvement in genetic resistance to bone marrow transplantation.
Lotzová E; Gallagher MT; Trentin JJ
Transplant Proc; 1976 Sep; 8(3):477-82. PubMed ID: 185761
[No Abstract] [Full Text] [Related]
11. Polysaccharides in fungi. XXXVII. Immunomodulating activities of carboxymethylated derivatives of linear (1-->3)-alpha-D-glucans extracted from the fruiting bodies of Agrocybe cylindracea and Amanita muscaria.
Yoshida I; Kiho T; Usui S; Sakushima M; Ukai S
Biol Pharm Bull; 1996 Jan; 19(1):114-21. PubMed ID: 8820922
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of (1-->3)-beta-D-glucan in mice.
Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T
Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of glucan in a murine model of hepatic metastatic disease.
Williams DL; Sherwood ER; McNamee RB; Jones EL; Di Luzio NR
Hepatology; 1985; 5(2):198-206. PubMed ID: 3884476
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the antitumor effect and tissue distribution of highly branched (1-->3)-beta-D-glucan, SSG, by carrageenan.
Suda M; Ohno N; Adachi Y; Yadomae T
Biol Pharm Bull; 1995 May; 18(5):772-5. PubMed ID: 7492998
[TBL] [Abstract][Full Text] [Related]
15. [How does polyvinylpyridine N-oxide decrease the cytotoxic effect of SiO2 particles?].
Korkina LG; Deeva IB; Velichkovskiĭ BT
Gig Tr Prof Zabol; 1988 Jan; (1):8-13. PubMed ID: 2833430
[No Abstract] [Full Text] [Related]
16. Conformation-dependent change in antitumor activity of linear and branched (1----3)-beta-D-glucans on the basis of conformational elucidation by carbon-13 nuclear magnetic resonance spectroscopy.
Yoshioka Y; Uehara N; Saitô H
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1221-6. PubMed ID: 1394638
[TBL] [Abstract][Full Text] [Related]
17. Serum components induce beta-D-glucan-inhibitable uptake of zymosan particles by murine peritoneal macrophages.
Suzuki T; Ohno N; Adachi Y; Yadomae T
Biol Pharm Bull; 1993 Mar; 16(3):223-7. PubMed ID: 8364464
[TBL] [Abstract][Full Text] [Related]
18. Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator--yeast carboxymethyl glucan.
Kogan G; Sandula J; Korolenko TA; Falameeva OV; Poteryaeva ON; Zhanaeva SY; Levina OA; Filatova TG; Kaledin VI
Int Immunopharmacol; 2002 May; 2(6):775-81. PubMed ID: 12095168
[TBL] [Abstract][Full Text] [Related]
19. Specific passive immunotherapy of experimental lymphoma. Effects of macrophage toxic drugs.
Gerlier D; Avice T; Doré JF
Biomedicine; 1979 Jul; 31(4):106-10. PubMed ID: 226195
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
